A year like no other: The Annual Review 2020 has been published
The approval of the breakthrough COVID19 vaccine and seven approvals for new drugs or indications: The 2020 Annual Report summarizes the important work of Pfizer.
The 2020 Annual Review summarizes the important work Pfizer did in 2020. The approval of the breakthrough vaccine to prevent COVID-19 is certainly a historic milestone: amid the most devastating pandemic of this century, we brought hope to people around the world. While working on the vaccine we also continued to deliver for patients across all our therapeutic areas. This included seven regulatory approvals for either new medicines or indications – including treatments for colorectal cancer, cardiomyopathy and acute myeloid leukemia.
For the first time, this year's Annual Review also includes, an ESG report that highlights progress in environmental, social and governance areas – such as measures to address disparities and create a healthier and more equitable world for all.
Download Pfizer 2020 Annual Report
Science will win
It has before. It will again. We believe that SCIENCE will win.
We proudly stand with our scientists who work tirelessly in the pursuit of treatments that save and extend lives.
Watch on youtube
A space for creativity: Our Innovation Space
"A brilliant space with charm" is how Clemens Stief described the new room at the opening. The room is for creating innovative ideas, developing new solutions and out of the box thinking - a space for free thoughts.
The transformation of the former electrical warehouse was directed by Sergio Capobianco, who created an inspiring place with bold colors and lots of wood.
Peter Neske is particularly proud of the "Freiburg fingerprint" which the premises display by pictures with examples of green innovation in the region.
The space on the Freiburg site is available to all Pfizer employees.
"Vision Health Pioneers": Second round of startup funding is in the starting blocks
Innovation, entrepreneurship and new technologies: Within the "Vision Health Pioneers" incubator, Pfizer supports start-ups in the healthcare sector as a partner. The funding program will enter its second round in January 2021.
The participating startups can expect nine months of non-material and financial support. Training, a free coworking space, access to technology and network, business opportunities and equity-free financing of up to 72,000 euros per team form the core of the Health Pioneers program. Our two hub members Vivian Otto and Lorenz Winker also participate on the jury and as mentors.
The winners will be announced shortly. We look forward to a successful second round with the new "Vision Health Pioneers"!